What is dexmethylphenidate (Azstarys) used to treat
Dexmethylphenidate (Azstarys) is a new central nervous system stimulant prescription drug, mainly used to treat attention deficit hyperactivity disorder (ADHD) in children and adults aged 6 years and older. This type of disease manifests itself as difficulty concentrating, impulsive behavior, and hyperactivity. The main mechanism of action of Azstarys is to regulate the balance of dopamine and norepinephrine in the brain, thereby helping to improve concentration, control impulsive behavior, and improve daily learning and work efficiency. Azstarys was developed by Corium Pharmaceuticals in the United States and was approved for marketing by the U.S. Food and Drug Administration (FDA) in March 2021.

Azstarys is unique in its complex pharmacological design. It consists of two ingredients: dexmethylphenidate and a prodrug called serdexmethylphenidate. This combination can achieve the dual mechanism of "immediate release + delayed release", that is, it takes effect quickly within a short time after taking the drug, while maintaining a long-term drug concentration, so that patients can maintain stable concentration throughout the day. This differs from traditional short-acting stimulant drugs, such as methylphenidate, which usually need to be taken multiple times a day. Azstarys can maintain long-lasting effects through a single administration, reducing fluctuations in blood drug concentrations and reducing patient compliance issues.
Clinical data show that Azstarys has shown good results in improving the core symptoms of ADHD, especially in improving attention span, behavioral control and learning concentration. For pediatric patients, parents generally report that they are well tolerated and less prone to reactions such as mood swings or over-excitement. At the same time, the drug effect of Azstarys usually covers more than 13 hours, which has obvious advantages for children who need to maintain stable behavioral performance in school and home environments.
Reference materials:https://azstarys.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)